Role of flagellin in Crohn's disease: Emblematic of the progress and enigmas in understanding inflammatory bowel disease

Inflammatory Bowel Diseases

Volumn 15, Issue 5, 2009, Pages 789-795

  Vijay Kumar, Matam ^a   Gewirtz, Andrew T ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Bacterial flagellin; Crohn's disease; Enteric microbiota

Indexed keywords

FLAGELLIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 1BETA; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; TOLL LIKE RECEPTOR 5;

ADAPTIVE IMMUNITY; CLOSTRIDIUM; COMMENSALISM; CROHN DISEASE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENTERITIS; ESCHERICHIA COLI; GASTROINTESTINAL MUCOSA; GENE ACTIVATION; GENE EXPRESSION; GENE FUNCTION; GENETIC POLYMORPHISM; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE DYSREGULATION; IMMUNOREACTIVITY; INFLAMMATION; INNATE IMMUNITY; KNOCKOUT GENE; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TARGETING; REVIEW; SALMONELLA;

CROHN DISEASE; FLAGELLIN; HUMANS;

EID: 67650340191     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20734     Document Type: Review

References (43)

1. Ley RE, Hamady M, Lozupone C, et al. Evolution of mammals and their gut microbes. Science. 2008;320:1647-1651.
2. Smythies LE, Sellers M, Clements RH, et al. Human intestinal macrophages display profound inflammatury anergy despite avid phagocytic and bacteriocidal activity. J Clin Invest. 2005;115:66-75.
3. Namba K, Vonderviszt F. Molecular architecture of bacterial flagellum. Q Rev Biophys. 1997;30:1-65.
4. Gewirtz AT, Simon PO Jr, Schmitt CK, et al. Salmonella typhimurium translocates flagellin across intestinal epithelia, inducing a proinflammatory response. J Clin Invest. 2001;107:99-109.
5. Subramanian N, Qadri A. Lysophospholipid sensing triggers secretion of flagellin from pathogenic salmonella. Nat Immunol. 2006;7:549-551.
6. Zeng H, Carlson AQ, Guo Y, et al. Flagellin is the major proinflammatory determinant of enteropathogenic Salmonella. J Immunol. 2003; 171: 3668-3674.
7. Smith KD, Andersen-Nissen E, Hayashi F, et al. Toll-like receptor 5 recognizes a conserved site on-flagellin requirod for protofilament formation and bacterial motility. Nat Immunol. 2003;4:1247-1253.
8. Johanesen PA, Dwinell MB. Flagellin-independent regulation of chemokine host defense in Campylobacter jejuni-infected intestinal epithelium. Infect Immun. 2006;74:3437-3447.
9. Gewirtz AT, Yu Y, Krishna US, et al. Helicobacter pylori flagellin evades toll-like receptor 5-mediated innate immunity. J Infect Dis. 2004;189:1914-1920.
10. Hayashi F, Smith KD, Ozinsky A, et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature. 2001;410: 1099-1103.
11. Gewirtz AT, Navas TA, Lyons S, et al. Cutting edge: bacterial flagellin activates basolaterally expressed tlr5 to induce epithelial proinflammatory gene expression. J Immunol. 2001;167:1882-1885.
12. Rhee SH, Im E, Riegler M, et al. Pathophysiological role of Toll-like receptor 5 engagement by bacterial flagellin in colonic inflammation. Proc Natl Acad Sci U S A. 2005;102:13610-13615.
13. Lyons S, Wang L, Casanova JE, et al. Salmonella typhimurium transcytoses flagellin via an SP12-mediated vesicular transport pathway. J Cell Sci. 2004;117:5771-5780.
14. Means TK, Hayashi F, Smith KD, et al. The Toll-like receptor 5 stimulus bacterial flagellin induces maturation and chemokine production in human dendritic cells. J Immunol. 2003;170:5165-5175.
15. Uematsu S, Jang MH, Chevrier N, et al. Detection of pathogenic intestinal bacteria by Toll-like receptor 5 on intestinal CD11c(+) lamina propria cells. Nat Immunol. 2006;7:868-874.
16. Monteleone I, Platt AM, Jaensson E, et al. IL-10-dependent partial refractoriness to Toll-like receptor stimulation modulates gut mucosal dendritic cell function. Eur J Immunol. 2008;38:1533-1547.
17. Franchi L, Amer A, Body-Malapel M, et al. Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta in salmonella-infected macrophages. Nat Immunol. 2006;7:576-582.
18. Lodes MJ, Cong Y, Elson CO, et al. Bacterial flagellin is a dominant antigen in Crohn disease. J Clin Invest. 2004;113:1296-1306.
19. Sanders CJ, Yu Y, Moore DA 3rd, et al. Humoral immune response to flagellin requires T cells and activation of innate immunity. J Immunol. 2006;177:2810-2818.
20. Duck LW, Walter MR, Novak J, et al. Isolation of flagallated bacteria implicated in Crohn's disease. Inflamm Bowel Dis. 2007;13:1191-1201.
21. Sitaraman SV, Klapproth JM, Moore DA 3rd, et al. Elevated flagellin-specific immunoglobulins in Crohn's disease. Am J Physiol Gastrointest Liver Physiol. 2005;288:G403-406.
22. Subramanian S, Rhodes JM, Hart CA, et al. Characterization of epithelial IL-8 response to inflammatory bowel disease mucosal E. coli and its inhibition by mesalamine. Inflamm Bowel Dis. 2008;14:162-175.
23. Petrof EO, Musch MW, Ciancio M, et al. Flagellin is required for salmonella-induced expression of beat shock protein Hsp25 in intestinal epithelium. Am J Physiol Gastroiniest Liver Physiol. 2008;294:G808-818.
24. Zeng H, Wu H, Sloane V, et al. Flagellin/TLR5 responses in epithelia reveal intertwined activation of inflammatory and apoptotic pathways. Am J Physiol Gastrointest Liver Physiol. 2005;290:96-108.
25. Neish AS. Flagellin induced inflammation and anti-apoptosis. Am J Physiol. 2008 (in press).
26. Schmitt CK, Ikeda JS, Darnell SC, et al. Absence of all components of the flagellar export and synthesis machinery differentially alters virulence of Salmonella enterica serovar-Typhimurium in models of typhoid fever, survival in macrophages, tissue culture invasiveness, and calf enterocolitis. Infect Immun. 2001;69:5619-5625.
27. Vijay-Kumar M, Wu H, Jones R, et al. Flagellin suppresses epithelial apoptosis and limits disease during enteric infection. Am J Pathol. 2006;169:1686-1700.
28. Vijay-Kumar M, Aitken JD, Kumar A, et al. Toll-like receptor 5-deficient mice have dysregulated intestinal gene expression and nonspecific resistance to Salmonella-induced-typhoid-like disease. Infect Immun. 2008;76:1276-1281.
29. Carvalho FA, Barnich N, Sauvinet P, et al. Crohn's disease-associated Escherichia coli LF82 aggravates colitis in injured mouse colon via signaling by flagellin. Inflamm Bowel Dis. 2008;14:1051-1060.
30. Vijay-Kumar M. Aitken JD, Sanders CJ, et al. Flagellin treatment protects against chemicals, bacteria, viruses, and radiation. J Immunol. 2008;180:8280-8285.
31. Gewirtz AT, Vijay-Kumar M, Brant SR, et al. Dominant-negative TLR5 polymorphism reduces adaptive immune response to flagellin and negatively associates with Crohn's disease. Am J Physiol Gastrointest Liver Physiol. 2006;290:1157-1163.
32. Vijay-Kumar M, Sanders CJ, Taylor RT, et al. Deletion of TLR5 results in spontaneous colitis in mice. J Clin Invest. 2097;117:3909-3921.
33. Nenci A, Becker C, Wullaert A, et al. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature. 2007;446:557-561.
34. Dave SH, Tilstra JS, Matsuoka K, et al. Amelioration of chronic murine colitis by peptide-mediated transduction of the IkappaB kinase inhibitor NEMO binding domain peptide. J Immunol. 2007;179:7852-7859.
35. Adams RJ, Heazlewood SP, Gilshenan KS, et al. IgG antibodies against common gut bacteria are more diagnostic for Crohn's disease than IgG against mannan or flagellin. Am J Gastroenterol. 2008;103:386-396.
36. Konrad A, Cong Y, Duck W, et al. Tight mucosal compartmentation of the murine immune response to antigens of the enteric microbiota. Gastroenterology. 2006;130:2050-2059.
37. Cho JH. The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol. 2008;8:458-466.
38. Devlin SM, Yang H, Ippoliti A, et al. NOD2 variants and antibody response to microbial antigens in Crohn's disease patients and their unaffected relatives. Gastroenterology. 2007;132:576-586.
39. Papadakis KA, Yang H, Ippoliti A, et al. Anti-flagellin (CBir1) phenotypic and genetic Crohn's disease associations. Inflamm Bowel Dis. 2007;13:524-530.
40. Takedatsu H, Taylor KD, Elson CO, et al. Reduced NF-κB expression in cell lines from anti-CBir1-associated NfκB1 haplotypes. Inflamm Bowel Dis. 2008 (in press).
41. Fleshner P, Ippoliti A, Dubinsky M, et al. Both preoperative perinuclear antineutrophil cytoplasmic antibody and anti-CBir1 expression in ulcerative colitis patients influence pouchitis development after ileal pouchanal anastomosis. Clin Gastroenterol Hepatol. 2008;6:561-568.
42. Dubinsky MC, Kugathasan S, Mei L, et al. Increased immune reactivity predicts aggressive complicating Crohn's disease in children. Clin Gastroenterol Hepatol. 2008 (in press).
43. Targan SR, Landers CJ, Yang H, et al. Antibodies a CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease. Gastroenterology. 2005;128:2020-2028.